Abciximab and Heparin versus Bivalirudin for Non―ST-Elevation Myocardial Infarction
- Author
- KASTRATI, Adnan1 ; NEUMANN, Franz-Josef3 ; SEYFARTH, Melchior4 ; GICK, Michael3 ; ANTONIUCCI, David5 ; SCHÖMIG, Albert2 ; BERGER, Peter B6 ; MEHILLI, Julinda1 ; SCHULZ, Stefanie1 ; MASSBERG, Steffen1 ; BYRNE, Robert A1 ; FERENC, Miroslaw3 ; LAUGWITZ, Karl-Ludwig2 ; PACHE, Jürgen1 ; OTT, Ilka1 ; HAUSLEITER, Jörg1
[1] Deutsches Herzzentrum, Technische Universität, Munich, Germany
[2] Medizinische Klinik rechts der Isar, Technische Universität, Munich, Germany
[3] Herz-Zentrum, Bad Krozingen (F.-J.N., M.F., M.G.); and HELIOS Klinikum Wuppertal, Wuppertal, Germany
[4] Universität Witten/Herdecke, Witten, Germany
[5] Careggi Hospital, Florence, Italy
[6] Geisinger Medical Center, Danville, PA, United States
ISAR-REACT 4 Trial Investigators, United States - Source
The New England journal of medicine. 2011, Vol 365, Num 21, pp 1980-1989, 10 p ; ref : 21 ref
- CODEN
- NEJMAG
- ISSN
- 0028-4793
- Scientific domain
- General medicine general surgery
- Publisher
- Massachusetts Medical Society, Waltham, MA
- Publication country
- United States
- Document type
- Article
- Language
- English
- Keyword (fr)
- Abciximab Anticoagulant Antithrombotique Bivalirudine Etude comparative Héparine Immunomodulateur Infarctus du myocarde Inhibiteur thromboagrégation Médecine Susdécalage ST Anti-GP IIb-IIIa Antagoniste du récepteur GP IIb/IIIa Anticorps monoclonal Antithrombine Cardiopathie coronaire Enzyme Glycoprotéine IIbIIIa Glycosaminoglycane Hydrolases Inhibiteur enzyme Pathologie de l'appareil circulatoire Pathologie du myocarde Peptidases Peptide Polypeptide Récepteur biologique Serine endopeptidases Thrombin
- Keyword (en)
- Abciximab Anticoagulant Antithrombotic agent Bivalirudin Comparative study Heparin Immunomodulator Myocardial infarction Antiplatelet agent Medicine ST elevation Platelet glycoprotein IIb/IIIa receptor antagonist Monoclonal antibody Antithrombin Coronary heart disease Enzyme Glycoprotein IIbIIIa Glycosaminoglycan Hydrolases Enzyme inhibitor Cardiovascular disease Myocardial disease Peptidases Peptides Polypeptide Biological receptor Serine endopeptidases Thrombin
- Keyword (es)
- Abciximab Anticoagulante antitrombōtico Bivalirudina Estudio comparativo Heparina Inmunomodulador Infarto miocardio Inhibidor tromboagregación Medicina ST elevación(ECG) Antagonista del receptor glicoproteína IIb/IIIa Anticuerpo monoclonal Antitrombina Cardiopatía coronaria Enzima Glicoproteína IIbIIIa Glicosaminoglicano Hydrolases Inhibidor enzima Aparato circulatorio patología Miocardio patología Peptidases Péptido Polipéptido Receptor biológico Serine endopeptidases Thrombin
- Classification
- Pascal
- 002 Biological and medical sciences / 002B Medical sciences / 002B12 Cardiology. Vascular system / 002B12A Heart / 002B12A03 Coronary heart disease
- Pascal
- 002 Biological and medical sciences / 002B Medical sciences / 002B12 Cardiology. Vascular system / 002B12A Heart / 002B12A05 Myocarditis. Cardiomyopathies
- Discipline
- Cardiology. Circulatory system Generalities in medical sciences
- Origin
- Inist-CNRS
- Database
- PASCAL
- INIST identifier
- 25244679
Sauf mention contraire ci-dessus, le contenu de cette notice bibliographique peut être utilisé dans le cadre d’une licence CC BY 4.0 Inist-CNRS / Unless otherwise stated above, the content of this bibliographic record may be used under a CC BY 4.0 licence by Inist-CNRS / A menos que se haya señalado antes, el contenido de este registro bibliográfico puede ser utilizado al amparo de una licencia CC BY 4.0 Inist-CNRS
Access to the document
Install on your browser
DOI
10.1056/NEJMoa1109596 
https://dx.doi.org/10.1056/NEJMoa1109596
"O:13:\"PanistOpenUrl\":36:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000idc\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:21:\"10.1056\/NEJMoa1109596\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:85:\"Abciximab and Heparin versus Bivalirudin for Non\u2015ST-Elevation Myocardial Infarction\";s:9:\"\u0000*\u0000jtitle\";s:35:\"The New England journal of medicine\";s:9:\"\u0000*\u0000stitle\";s:15:\"N. Engl. j. med\";s:7:\"\u0000*\u0000date\";s:4:\"2011\";s:9:\"\u0000*\u0000volume\";s:3:\"365\";s:8:\"\u0000*\u0000issue\";s:2:\"21\";s:8:\"\u0000*\u0000spage\";s:4:\"1980\";s:8:\"\u0000*\u0000epage\";s:4:\"1989\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0028-4793\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:8:\"KASTRATI\";s:10:\"\u0000*\u0000aufirst\";s:5:\"Adnan\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:15:{i:0;s:20:\"NEUMANN, Franz-Josef\";i:1;s:18:\"SEYFARTH, Melchior\";i:2;s:13:\"GICK, Michael\";i:3;s:17:\"ANTONIUCCI, David\";i:4;s:16:\"SCH\u00d6MIG, Albert\";i:5;s:15:\"BERGER, Peter B\";i:6;s:16:\"MEHILLI, Julinda\";i:7;s:16:\"SCHULZ, Stefanie\";i:8;s:17:\"MASSBERG, Steffen\";i:9;s:15:\"BYRNE, Robert A\";i:10;s:16:\"FERENC, Miroslaw\";i:11;s:21:\"LAUGWITZ, Karl-Ludwig\";i:12;s:14:\"PACHE, J\u00fcrgen\";i:13;s:9:\"OTT, Ilka\";i:14;s:17:\"HAUSLEITER, J\u00f6rg\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"NEJMAG\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:85:\"Abciximab and Heparin versus Bivalirudin for Non\u2015ST-Elevation Myocardial Infarction\";s:8:\"\u0000*\u0000place\";s:11:\"Waltham, MA\";s:6:\"\u0000*\u0000pub\";s:29:\"Massachusetts Medical Society\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:2:\"10\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Panist access
"O:12:\"IstexOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:21:\"10.1056\/NEJMoa1109596\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:85:\"Abciximab and Heparin versus Bivalirudin for Non\u2015ST-Elevation Myocardial Infarction\";s:9:\"\u0000*\u0000jtitle\";s:35:\"The New England journal of medicine\";s:9:\"\u0000*\u0000stitle\";s:15:\"N. Engl. j. med\";s:7:\"\u0000*\u0000date\";s:4:\"2011\";s:9:\"\u0000*\u0000volume\";s:3:\"365\";s:8:\"\u0000*\u0000issue\";s:2:\"21\";s:8:\"\u0000*\u0000spage\";s:4:\"1980\";s:8:\"\u0000*\u0000epage\";s:4:\"1989\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0028-4793\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:8:\"KASTRATI\";s:10:\"\u0000*\u0000aufirst\";s:5:\"Adnan\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:15:{i:0;s:20:\"NEUMANN, Franz-Josef\";i:1;s:18:\"SEYFARTH, Melchior\";i:2;s:13:\"GICK, Michael\";i:3;s:17:\"ANTONIUCCI, David\";i:4;s:16:\"SCH\u00d6MIG, Albert\";i:5;s:15:\"BERGER, Peter B\";i:6;s:16:\"MEHILLI, Julinda\";i:7;s:16:\"SCHULZ, Stefanie\";i:8;s:17:\"MASSBERG, Steffen\";i:9;s:15:\"BYRNE, Robert A\";i:10;s:16:\"FERENC, Miroslaw\";i:11;s:21:\"LAUGWITZ, Karl-Ludwig\";i:12;s:14:\"PACHE, J\u00fcrgen\";i:13;s:9:\"OTT, Ilka\";i:14;s:17:\"HAUSLEITER, J\u00f6rg\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"NEJMAG\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:85:\"Abciximab and Heparin versus Bivalirudin for Non\u2015ST-Elevation Myocardial Infarction\";s:8:\"\u0000*\u0000place\";s:11:\"Waltham, MA\";s:6:\"\u0000*\u0000pub\";s:29:\"Massachusetts Medical Society\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:2:\"10\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Istex access
"O:16:\"UnpaywallOpenUrl\":35:{s:8:\"\u0000*\u0000email\";s:27:\"assistance-portail@inist.fr\";s:6:\"\u0000*\u0000fmt\";N;s:6:\"\u0000*\u0000doi\";s:21:\"10.1056\/NEJMoa1109596\";s:6:\"\u0000*\u0000pii\";N;s:7:\"\u0000*\u0000pmid\";N;s:9:\"\u0000*\u0000atitle\";N;s:9:\"\u0000*\u0000jtitle\";N;s:9:\"\u0000*\u0000stitle\";N;s:7:\"\u0000*\u0000date\";N;s:9:\"\u0000*\u0000volume\";N;s:8:\"\u0000*\u0000issue\";N;s:8:\"\u0000*\u0000spage\";N;s:8:\"\u0000*\u0000epage\";N;s:8:\"\u0000*\u0000pages\";N;s:7:\"\u0000*\u0000issn\";N;s:8:\"\u0000*\u0000eissn\";N;s:9:\"\u0000*\u0000aulast\";N;s:10:\"\u0000*\u0000aufirst\";N;s:9:\"\u0000*\u0000auinit\";N;s:10:\"\u0000*\u0000auinitm\";N;s:5:\"\u0000*\u0000au\";N;s:9:\"\u0000*\u0000aucorp\";N;s:7:\"\u0000*\u0000isbn\";N;s:8:\"\u0000*\u0000coden\";N;s:8:\"\u0000*\u0000genre\";N;s:7:\"\u0000*\u0000part\";N;s:9:\"\u0000*\u0000btitle\";N;s:8:\"\u0000*\u0000title\";N;s:8:\"\u0000*\u0000place\";N;s:6:\"\u0000*\u0000pub\";N;s:10:\"\u0000*\u0000edition\";N;s:9:\"\u0000*\u0000tpages\";N;s:9:\"\u0000*\u0000series\";N;s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";N;}"
Unpaywall access
"O:16:\"EuropePMCOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:21:\"10.1056\/NEJMoa1109596\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:85:\"Abciximab and Heparin versus Bivalirudin for Non\u2015ST-Elevation Myocardial Infarction\";s:9:\"\u0000*\u0000jtitle\";s:35:\"The New England journal of medicine\";s:9:\"\u0000*\u0000stitle\";s:15:\"N. Engl. j. med\";s:7:\"\u0000*\u0000date\";s:4:\"2011\";s:9:\"\u0000*\u0000volume\";s:3:\"365\";s:8:\"\u0000*\u0000issue\";s:2:\"21\";s:8:\"\u0000*\u0000spage\";s:4:\"1980\";s:8:\"\u0000*\u0000epage\";s:4:\"1989\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0028-4793\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:8:\"KASTRATI\";s:10:\"\u0000*\u0000aufirst\";s:5:\"Adnan\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:15:{i:0;s:20:\"NEUMANN, Franz-Josef\";i:1;s:18:\"SEYFARTH, Melchior\";i:2;s:13:\"GICK, Michael\";i:3;s:17:\"ANTONIUCCI, David\";i:4;s:16:\"SCH\u00d6MIG, Albert\";i:5;s:15:\"BERGER, Peter B\";i:6;s:16:\"MEHILLI, Julinda\";i:7;s:16:\"SCHULZ, Stefanie\";i:8;s:17:\"MASSBERG, Steffen\";i:9;s:15:\"BYRNE, Robert A\";i:10;s:16:\"FERENC, Miroslaw\";i:11;s:21:\"LAUGWITZ, Karl-Ludwig\";i:12;s:14:\"PACHE, J\u00fcrgen\";i:13;s:9:\"OTT, Ilka\";i:14;s:17:\"HAUSLEITER, J\u00f6rg\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"NEJMAG\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:85:\"Abciximab and Heparin versus Bivalirudin for Non\u2015ST-Elevation Myocardial Infarction\";s:8:\"\u0000*\u0000place\";s:11:\"Waltham, MA\";s:6:\"\u0000*\u0000pub\";s:29:\"Massachusetts Medical Society\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:2:\"10\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Europe PubMed Central access
"O:11:\"BaseOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:21:\"10.1056\/NEJMoa1109596\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:85:\"Abciximab and Heparin versus Bivalirudin for Non\u2015ST-Elevation Myocardial Infarction\";s:9:\"\u0000*\u0000jtitle\";s:35:\"The New England journal of medicine\";s:9:\"\u0000*\u0000stitle\";s:15:\"N. Engl. j. med\";s:7:\"\u0000*\u0000date\";s:4:\"2011\";s:9:\"\u0000*\u0000volume\";s:3:\"365\";s:8:\"\u0000*\u0000issue\";s:2:\"21\";s:8:\"\u0000*\u0000spage\";s:4:\"1980\";s:8:\"\u0000*\u0000epage\";s:4:\"1989\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0028-4793\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:8:\"KASTRATI\";s:10:\"\u0000*\u0000aufirst\";s:5:\"Adnan\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:15:{i:0;s:20:\"NEUMANN, Franz-Josef\";i:1;s:18:\"SEYFARTH, Melchior\";i:2;s:13:\"GICK, Michael\";i:3;s:17:\"ANTONIUCCI, David\";i:4;s:16:\"SCH\u00d6MIG, Albert\";i:5;s:15:\"BERGER, Peter B\";i:6;s:16:\"MEHILLI, Julinda\";i:7;s:16:\"SCHULZ, Stefanie\";i:8;s:17:\"MASSBERG, Steffen\";i:9;s:15:\"BYRNE, Robert A\";i:10;s:16:\"FERENC, Miroslaw\";i:11;s:21:\"LAUGWITZ, Karl-Ludwig\";i:12;s:14:\"PACHE, J\u00fcrgen\";i:13;s:9:\"OTT, Ilka\";i:14;s:17:\"HAUSLEITER, J\u00f6rg\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"NEJMAG\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:85:\"Abciximab and Heparin versus Bivalirudin for Non\u2015ST-Elevation Myocardial Infarction\";s:8:\"\u0000*\u0000place\";s:11:\"Waltham, MA\";s:6:\"\u0000*\u0000pub\";s:29:\"Massachusetts Medical Society\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:2:\"10\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Base Search access
"O:12:\"ArXivOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:21:\"10.1056\/NEJMoa1109596\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:85:\"Abciximab and Heparin versus Bivalirudin for Non\u2015ST-Elevation Myocardial Infarction\";s:9:\"\u0000*\u0000jtitle\";s:35:\"The New England journal of medicine\";s:9:\"\u0000*\u0000stitle\";s:15:\"N. Engl. j. med\";s:7:\"\u0000*\u0000date\";s:4:\"2011\";s:9:\"\u0000*\u0000volume\";s:3:\"365\";s:8:\"\u0000*\u0000issue\";s:2:\"21\";s:8:\"\u0000*\u0000spage\";s:4:\"1980\";s:8:\"\u0000*\u0000epage\";s:4:\"1989\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0028-4793\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:8:\"KASTRATI\";s:10:\"\u0000*\u0000aufirst\";s:5:\"Adnan\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:15:{i:0;s:20:\"NEUMANN, Franz-Josef\";i:1;s:18:\"SEYFARTH, Melchior\";i:2;s:13:\"GICK, Michael\";i:3;s:17:\"ANTONIUCCI, David\";i:4;s:16:\"SCH\u00d6MIG, Albert\";i:5;s:15:\"BERGER, Peter B\";i:6;s:16:\"MEHILLI, Julinda\";i:7;s:16:\"SCHULZ, Stefanie\";i:8;s:17:\"MASSBERG, Steffen\";i:9;s:15:\"BYRNE, Robert A\";i:10;s:16:\"FERENC, Miroslaw\";i:11;s:21:\"LAUGWITZ, Karl-Ludwig\";i:12;s:14:\"PACHE, J\u00fcrgen\";i:13;s:9:\"OTT, Ilka\";i:14;s:17:\"HAUSLEITER, J\u00f6rg\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"NEJMAG\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:85:\"Abciximab and Heparin versus Bivalirudin for Non\u2015ST-Elevation Myocardial Infarction\";s:8:\"\u0000*\u0000place\";s:11:\"Waltham, MA\";s:6:\"\u0000*\u0000pub\";s:29:\"Massachusetts Medical Society\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:2:\"10\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
arXiv access
